Aerie Pharmaceuticals Shares Fall 75% On Failed Phase 3 Trial
April 23, 2015 at 17:30 PM EDT
Shares of Aerie Pharmaceuticals Inc (NASDAQ: AERI) fell 75 percent in after-hours trading following an announcement of a failed Phase ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.